Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Privia Health Group Inc

PRVA
Current price
23.17 USD -0.1 USD (-0.43%)
Last closed 23.39 USD
ISIN US74276R1023
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 2 846 002 944 USD
Yield for 12 month +24.24 %
1Y
3Y
5Y
10Y
15Y
PRVA
21.11.2021 - 28.11.2021

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. The company also operates accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Address: 950 North Glebe Road, Arlington, VA, United States, 22203

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

29.30 USD

P/E ratio

213.27

Dividend Yield

Current Year

+1 736 390 000 USD

Last Year

+1 657 737 000 USD

Current Quarter

+460 900 000 USD

Last Quarter

+437 921 000 USD

Current Year

+176 853 000 USD

Last Year

+161 501 000 USD

Current Quarter

+47 967 000 USD

Last Quarter

+45 352 000 USD

Key Figures PRVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 24 250 000 USD
Operating Margin TTM 1.14 %
Price to Earnings 213.27
Return On Assets TTM 0.99 %
PEG Ratio
Return On Equity TTM 2.64 %
Wall Street Target Price 29.30 USD
Revenue TTM 1 736 390 016 USD
Book Value 5.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 4.60 %
Dividend Yield
Gross Profit TTM 176 852 992 USD
Earnings per share 0.11 USD
Diluted Eps TTM 0.11 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 24.50 %
Profit Margin 0.83 %

Dividend Analytics PRVA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History PRVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio TTM
Last Split Date

Stock Valuation PRVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 213.27
Forward PE 44.84
Enterprise Value Revenue 1.36
Price Sales TTM 1.64
Enterprise Value EBITDA 97.34
Price Book MRQ 4.48

Financials PRVA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PRVA

For 52 weeks

15.92 USD 26.04 USD
50 Day MA 23.80 USD
Shares Short Prior Month 4 427 103
200 Day MA 20.95 USD
Short Ratio 4.54
Shares Short 4 168 291
Short Percent 6.25 %